home.social

#antiretroviral — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #antiretroviral, aggregated by home.social.

  1. Even with #antiretroviral therapy, HIV-1 can still cause persistent inflammation in macrophages. This study shows that intron-containing #HIV1 RNA (icRNA) activates NLRP1 #inflammasome & induces IL-1β secretion in myeloid cells, independent of RIG-I-like receptors @PLOSBiology plos.io/45VTGBR

  2. Even with #antiretroviral therapy, HIV-1 can still cause persistent inflammation in macrophages. This study shows that intron-containing #HIV1 RNA (icRNA) activates NLRP1 #inflammasome & induces IL-1β secretion in myeloid cells, independent of RIG-I-like receptors @PLOSBiology plos.io/45VTGBR

  3. Even with #antiretroviral therapy, HIV-1 can still cause persistent inflammation in macrophages. This study shows that intron-containing #HIV1 RNA (icRNA) activates NLRP1 #inflammasome & induces IL-1β secretion in myeloid cells, independent of RIG-I-like receptors @PLOSBiology plos.io/45VTGBR

  4. Even with #antiretroviral therapy, HIV-1 can still cause persistent inflammation in macrophages. This study shows that intron-containing #HIV1 RNA (icRNA) activates NLRP1 #inflammasome & induces IL-1β secretion in myeloid cells, independent of RIG-I-like receptors @PLOSBiology plos.io/45VTGBR

  5. Even with #antiretroviral therapy, HIV-1 can still cause persistent inflammation in macrophages. This study shows that intron-containing #HIV1 RNA (icRNA) activates NLRP1 #inflammasome & induces IL-1β secretion in myeloid cells, independent of RIG-I-like receptors @PLOSBiology plos.io/45VTGBR

  6. New #antiretroviral alert! A new study in #PLOSBiology reveals a novel long-acting deoxyadenosine analog, MK-8527, that displays potent antiretroviral activity and favorable preclinical pharmacokinetic and off-target profiles in non-human primate models of #HIV infection.
    plos.io/45UfwV4

  7. Five #children see #HIV viral loads vanish after taking #antiretroviral drugs
    After putting children on antiretrovirals early in life to control HIV, doctors were keen to monitor progress and adherence to antiretroviral treatment, which stops HIV from replicating. Over following decade, something unusual happened. 5 children stopped coming to clinic to collect drugs, and when the team eventually tracked them down many months later, they appeared to be in perfect #health.
    arstechnica.com/health/2025/08

  8. Long-acting injectables can be a good option for people with adherence challenges | aidsmap aidsmap.com/news/mar-2024/long#Antiretroviral therapy (#ART) using #cabotegravir and #rilpivirine injections monthly or every other month can be an effective HIV treatment option for people who have difficulty maintaining viral suppression on daily pills due to suboptimal adherence, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2024).”

  9. Long-acting injectables can be a good option for people with adherence challenges | aidsmap aidsmap.com/news/mar-2024/long#Antiretroviral therapy (#ART) using #cabotegravir and #rilpivirine injections monthly or every other month can be an effective HIV treatment option for people who have difficulty maintaining viral suppression on daily pills due to suboptimal adherence, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2024).”

  10. Long-acting injectables can be a good option for people with adherence challenges | aidsmap aidsmap.com/news/mar-2024/long#Antiretroviral therapy (#ART) using #cabotegravir and #rilpivirine injections monthly or every other month can be an effective HIV treatment option for people who have difficulty maintaining viral suppression on daily pills due to suboptimal adherence, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2024).”

  11. Long-acting injectables can be a good option for people with adherence challenges | aidsmap aidsmap.com/news/mar-2024/long#Antiretroviral therapy (#ART) using #cabotegravir and #rilpivirine injections monthly or every other month can be an effective HIV treatment option for people who have difficulty maintaining viral suppression on daily pills due to suboptimal adherence, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2024).”

  12. Long-acting injectables can be a good option for people with adherence challenges | aidsmap aidsmap.com/news/mar-2024/long#Antiretroviral therapy (#ART) using #cabotegravir and #rilpivirine injections monthly or every other month can be an effective HIV treatment option for people who have difficulty maintaining viral suppression on daily pills due to suboptimal adherence, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2024).”

  13. A subset of white #blood #cells, known as #myeloid cells, can harbor #HIV in people who have been virally suppressed for years on #antiretroviral therapy, according to findings from a small study supported by the National Institutes of Health.
    #Virology #Microbiology #sflorg
    sflorg.com/2023/03/vi03272301.

  14. #HIV-infected people who receive #antiretroviral therapy form antibodies against #Sars-Cov-2 after the #Corona #vaccination with mRNA vaccines. However, your immune response to vaccination is less strong than that of healthy people
    #Covid19 #Medical #Virology #Immunology #sflorg
    sflorg.com/2022/12/med12092201

  15. Seit etwa 40 Jahren ist HIV/Aids bekannt. Einen Impfstoff gegen das Virus gibt es noch immer nicht, obwohl Forscher weltweit intensiv danach suchen. Aber warum ist das so kompliziert? Was macht das Virus so tückisch?
    Kein Impfstoff gegen HIV in Sicht | DW | 06.07.2020
    #HIV #Aids #Impfstoff #Immunsystem #AIDS-Forschung #Retroviren #antiretroviral #PrEP